In-Vitro Studies on the Protective Effect of Bacopa Monnieri on Oxidative Stress Induced Neurotoxici

Page 1

International Journal of Bio-Technology and Research (IJBTR) ISSN (P): 2249–6858; ISSN (E): 2249–796X Vol. 10, Issue 1, Jun 2020, 87-96 © TJPRC Pvt. Ltd.

IN-VITRO STUDIES ON THE PROTECTIVE EFFECT OF BACOPA MONNIERI ON OXIDATIVE STRESS INDUCED NEUROTOXICITY SREELAKSHMI. R & LEKSHMI. R Scholar, Department of Bio-Technology, Milad-E-Sherif Memorial College, Kayamkulam, Kerala University, India ABSTRACT Neurodegenerative diseases can be defined as, ‘the disorders with selective neuron loss’. The disorders result mainly when neurons in brain and peripheral nervous system suffer a functional loss and progressive death. Most of such conditions have no cure. This may result in ‘ataxias’ or ‘dementias’. In some of the neurodegenerative diseases such as Alzheimer’s disease and Parkinson’s disease; which are age related neurotoxicity arises mainly from protein aggregation. The attack of free radicals produced as a result of oxidative stress, on neurons also contributes to neurodegeneration. The free radicals which are toxic can cause protein and DNA degeneration, damage of tissues, inflammation and cell level apoptosis. Therefore, inhibiting aggregation of proteins and scavenging of free radicals will be potential therapeutic strategies for neurodegenerative disorders. It has been already proven that several phytochemicals like flavanoids can act as antioxidants scavenging stress induced free radicals in the brain. Here, we are

radicals. The study also aims to measure the neuroprotective activity of B.monnieri extracts. Phytochemical analysis was performed by qualitative assays which proved the presence of flavanoids and steroids. The plant extract was also found to have antioxidant potential which was confirmed by assay for reducing power. The anti apoptotic effect of B.monnieri extract were confirmed by FDA/EtBr staining. With potential anti-oxidant, free radical scavenging and anti apoptotic activity B.monnieri leaf extract may be used as an effective therapeutic agent in targeting neurodegenerative disorders.

Original Article

aiming to analyse the phytochemicals present in the leaf extract of Bacopamonnieri and how effectively it scavenges free

KEYWORDS: Neurodegeneration, Phytochemicals & Radical Scavenging

Received: Mar 01, 2020; Accepted: Mar 20, 2020; Published: May 20, 2020; Paper Id.: IJBTRJUN20208

1. INTRODUCTION Bacopa monnieri is a plant of great therapeutic importance. The use of B.monnieri in indigenous systems of medicine have been proven by several researchers. The alkaloid brahmine was isolated from B.monnieri in 1931.Several other alkaloids such as nicotine, herpestine, D-mannitol, saponin, hersaponin and potassium salts have also been isolated from B.monnieri extracts[1].Bacoside A and Bacoside B are two major saponins present in Bacopa extract which attributes to its nootropic activity[2].The plant extract also has memory enhancing activity, which is contributed by Bacoside A; chemically 3-(α-L-arabinopyranosyl)-O-ß-D glucopyranoside-10,20dihydroxy-16-keto-dammar-24-ene [3].Bacoside A and B are stereoisomers of which Bacoside A is levorotatory while the latter is dextrorotatory[4]. Other chemical constituents separated from the alcoholic extract of B.monnieri are triterpenoidsaponins like jujubogenin and pseudojujubogenin.Acid hydrolysis of Bacosides give aglycones bacogenin A1, A2, A3, A4 etc[5]. Phenylethnoid glycosides like monnierasides I, II and III and plantainoside B were isolated from the glycosidic fraction of B. monnieri [6]. Bacoside A is composed of four triglycosidicsaponins[7].Bacoside B has four diglycosidicsaponins[8].The plant aqueous extract has also given two dammarane glycosides[9], 20-O- α -Lwww.tjprc.org

editor@tjprc.org


Turn static files into dynamic content formats.

Create a flipbook
Issuu converts static files into: digital portfolios, online yearbooks, online catalogs, digital photo albums and more. Sign up and create your flipbook.